Home Evaluation of Cobas Integra® 800 under Simulated Routine Conditions in Six Laboratories
Article
Licensed
Unlicensed Requires Authentication

Evaluation of Cobas Integra® 800 under Simulated Routine Conditions in Six Laboratories

  • Francisco L. Redondo , Pilar Bermudez , Claudio Cocco , Francesca Colella , Maria Stella Graziani , Walter Fiehn , Thomas Hierl , Gisèle LeMoël , Anne Marie Belliard , Dieudonne Manene , Mourad Meziani , Maryann Liebel , Matthew J. McQueen and Wolfgang Stockmann
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 41 Issue 3

Abstract

The new selective access analyser Cobas Integra® 800 from Roche Diagnostics was evaluated in an international multicentre study at six sites. Routine simulation experiments showed good performance and full functionality of the instrument and provocation of anomalous situations generated no problems. The new features on Cobas Integra® 800, namely clot detection and dispensing control, worked according to specifications. The imprecision of Cobas Integra® 800 fulfilled the proposed quality specifications regarding imprecision of analytical systems for clinical chemistry with few exceptions. Claims for linearity, drift, and carry-over were all within the defined specifications, except urea linearity. Interference exists in some cases, as could be expected due to the chemistries applied. Accuracy met the proposed quality specifications, except in some special cases. Method comparisons with Cobas Integra 700 showed good agreement; comparisons with other analysis systems yielded in several cases explicable deviations. Practicability of Cobas Integra® 800 met or exceeded the requirements for more than 95% of all attributes rated. The strong points of the new analysis system were reagent handling, long stability of calibration curves, high number of tests on board, compatibility of the sample carrier to other Roche systems, and the sample integrity check for more reliable analytical results.

The improvement of the workflow offered by the 5-position rack and STAT handling like on Cobas Integra® 800 makes the instrument attractive for further consolidation in the medium-sized laboratory, for dedicated use of special analytes, and/or as back-up in the large routine laboratory.

:
Published Online: 2005-06-01
Published in Print: 2003-03-24

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. 3rd Conference on Hyperhomocysteinemia Saarbrücken, Germany, 11–12 April 2003, Saarland University
  2. Platelet Receptors and Their Role in Diseases
  3. Real-Time RT-PCR for the Measurement of Prostate-Specific Antigen mRNA Expression in Benign Hyperplasia and Adenocarcinoma of Prostate
  4. Detection of a Novel Exon 4 Low-Density Lipoprotein Receptor Gene Deletion in a Swiss Family with Severe Familial Hypercholesterolemia
  5. Absence of Known Familial Hemiplegic Migraine (FHM) Mutations in the CACNA1A Gene in Patients with common Migraine: Implications for Genetic Testing
  6. Association between 5,10-Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Conotruncal Heart Defects
  7. Rapid and Reliable Genotyping of the C181T Polymorphism in the Bradykinin B2 Receptor Gene
  8. Steroids, Sex Hormone-Binding Globulin, Homocysteine, Selected Hormones and Markers of Lipid and Carbohydrate Metabolism in Patients with Severe Hypothyroidism and Their Changes Following Thyroid Hormone Supplementation
  9. Anaerobic Bacteremia: The Yield of Positive Anaerobic Blood Cultures: Patient Characteristics and Potential Risk Factors
  10. Genotyping of Alcohol Dehydrogenase Type 2 and 3 Using a Two-Buffer Polyacrylamide Gel Electrophoresis System
  11. Effect of Partial Proteolysis on the Activation Energy of β-N-Acetylhexosaminidase Precursor and Mature Forms
  12. Angiogenin and Gestational Trophoblastic Tumors, a Promising Prognostic Marker
  13. Carbohydrate 19-9 Antigen Is Not a Marker of Liver Disease in Patients with Cystic Fibrosis
  14. Assay Using Succinyldithiocholine as Substrate: The Method of Choice for the Measurement of Cholinesterase Catalytic Activity in Serum to Diagnose Succinyldicholine Sensitivity
  15. National External Quality Assessment Scheme for Lymphocyte Immunophenotyping in Belgium
  16. Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussion
  17. Guidelines for the Analysis of Bence Jones Protein
  18. Discordance Rate, a New Concept for Combining Diagnostic Decisions with Analytical Performance Characteristics. 1. Application in Method or Sample System Comparisons and in Defining Decision Limits
  19. Urinary Homogentisic Acid in Alkaptonuric and Healthy Children
  20. The Influence of Hemolysis, Turbidity and Icterus on the Measurements of CK-MB, Troponin I and Myoglobin
  21. Evaluation of Cobas Integra® 800 under Simulated Routine Conditions in Six Laboratories
  22. Guidelines for the Laboratory Investigation of Inherited Thrombophilias. Recommendations for the First Level Clinical Laboratories
  23. Detection of PvuII Polymorphism within Intron 1 of ESR1 Gene by Real-Time PCR
  24. Meetings and Awards
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2003.058/html
Scroll to top button